Interested in submitting to this journal? We recommend that you review the About the Journal page for the journal's section policies, as well as the Author Guidelines. Authors need to Register with the journal prior to submitting or, if already registered, can simply log in and begin the five-step process.


Journal of Drug Delivery and Therapeutics is committed to the long-term preservation of its content. All articles published by the journal are preserved by PORTICO. In addition, journal encourage authors to archive the published version of their articles on their institutional repositories and as well as other appropriate websites.


The journal allows authors to deposit all versions of their paper (submitted, accepted, and published versions) in an institutional or other repository of their choice.

OCLC/OAIster (OAIster: Catalog of open access resources | OCLC)

Journal of Drug Delivery and Therapeutics is an Open Access journal. Publishing an article in this Journal requires Article Processing Charges that will be billed to the submitting author following the acceptance of an article for publication. Apart from these Article Process Charges, there are no submission charges, page charges, or color charges. The fees to be paid following the acceptance of an article See Details:

Waiver Policy as per World Bank Country Classification
We provide a waiver of Article Processing Charges to authors based on country classification by World Bank and Processing charges decided as per countries classified World Bank Country Classification
We can also waive 100% in some special condition depend on if there is no funding and author not able to charge any fees. In order to apply for a waiver, please request one before submitting your manuscript by sending an email to

For more details about the list of countries as per the classification of World Bank' go to below Link;

World Bank Country Classification

All Authors publishing in Journal of Drug Delivery and Therapeutics must declare all financial disclosures and conflicts of interest in the article file of manuscripts submitted for publication. For more information on Conflict of Interest, see the guidelines from the ICMJE.

All human studies submitted for publication in Journal of Drug Delivery and Therapeutics require informed consent and ethics committee approval. If waiver of consent was granted by the ethics committee in the case of retrospective studies not impacting on patient confidentiality or patient rights, this must be clearly stated in the cover letter and manuscript.

Any investigations involving humans and animals should be approved by the Institutional Review Board and Animal Care Committee, respectively, of the institution where the study took place. Journal of Drug Delivery and Therapeutics will not consider any studies involving humans or animals without the appropriate approval. If no formal ethics committee is available, the authors should indicate whether the procedures were compliant with the Helsinki Declaration as revised in 2008. Informed consent should be obtained, unless waived by the Institutional Review Board, from patients who participated in clinical investigations. Human subjects should not be identifiable, such that patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. If experiments involve animals, the research should be based on national or institutional guidelines for animal care and use. Original articles submitted to Journal of Drug Delivery and Therapeutics that address any investigation involving humans and animals should include a description about whether
the study was conducted under an approval by the Institutional Review Board (with or without patient informed consent) and animal care committee, respectively, of the institution where the study was conducted.